Post by
Barewood on Apr 10, 2018 12:17pm
We will
have news soon, I'm sure! Update regarding Neovasc's "prototype". As I had posted this earlier: "The second key strategic area of focus for us in the mitral valve space is the now initiated development of the transfemoral, trans-septal version of the Tiara mitral valve, the one that we believe has the potential to lead to a breakthrough for the optimal treatment of severe mitral valve regurgitation while providing a safe and broadly usable implantation technique." This statement was conveyed on March 28 during the Earnings Call. It has been 2 weeks, so anytime soon. It would be nice to hear of the progress that is being made.
Comment by
Dollarpee on Apr 10, 2018 12:24pm
Loaded more @ 0.07 and 0.075